Vicore Pharma Holding AB ADR (VCRE) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	760.00K	419.00K	602.00K	2.21M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	99.16M	113.04M	102.60M	118.85M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	17.65M	22.06M	21.51M	33.02M
Operating expense	116.81M	135.10M	124.11M	151.87M
Total operating expenses	116.81M	135.10M	124.11M	151.87M
Operating income	-116.05M	-134.68M	-123.50M	-149.65M
Other non operating income	1.00K	-	-	-
EBT including unusual items	-113.47M	-137.10M	-108.53M	-142.67M
EBT excluding unusual items	-113.47M	-137.10M	-108.53M	-142.67M
Income tax expense	-	-	86.00K	173.00K
Effective tax rate	-	-	-0.08%	-0.12%
Other operating expenses	-	-	-	-
Net income	-113.47M	-137.10M	-108.62M	-142.84M
Net profit margin	-14,930.66%	-32,721.48%	-18,042.52%	-6,454.77%
Earnings per share	-0.48	-0.54	-0.39	-0.51
Interest and investment income	5.96M	45.52M	15.96M	7.43M
Interest expense	-3.47M	-	-643.00K	-1.00K
Net interest expenses	2.49M	45.52M	15.32M	7.43M
Depreciation and amortization charges	-	-	-	-
EBITDA	-115.49M	-134.12M	-	-
Gain or loss from assets sale	-	-	-	-

Finance